Cagoco, Nenia .

HRN: 25-80-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/25/2024
10/02/2024
IV
500 Mg
Q8
PROM; Thickly MSAF
Waiting Final Action 
09/25/2024
CEFUROXIME 500MG (TAB)
09/25/2024
10/02/2024
PO
500mg
BID
S/P NSVD, Thinly MSAF
Waiting Final Action 
09/25/2024
METRONIDAZOLE 500MG (TAB)
09/25/2024
10/02/2024
PO
500mg
TID
S/P NSVD, Thinly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: